α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration von Abdelmotilib, Hisham, Maltbie, Tyler, Delic, Vedad, Liu, Zhiyong, Hu, Xianzhen, Fraser, Kyle B, Moehle, Mark S, Stoyka, Lindsay, Anabtawi, Nadia, Krendelchtchikova, Valentina, Volpicelli-Daley, Laura A, West, Andrew

Volltext

LRRK2 inhibition attenuates microglial inflammatory responses von Moehle, Mark S, Webber, Philip J, Tse, Tonia, Sukar, Nour, Standaert, David G, DeSilva, Tara M, Cowell, Rita M, West, Andrew B

Volltext

Abrogation of α-synuclein–mediated dopaminergic neurodegeneration in LRRK2-deficient rats von Daher, João P. L., Volpicelli-Daley, Laura A., Blackburn, Jonathan P., Moehle, Mark S., West, Andrew B.

Volltext

Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodents von West, Andrew B., Cowell, Rita M., Daher, João P.L., Moehle, Mark S., Hinkle, Kelly M., Melrose, Heather L., Standaert, David G., Volpicelli-Daley, Laura A.

Volltext

Corrigendum to “α-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic Neurodegeneration” [Neurobiol. Dis., Volume 105 (2017) Article 84, 98]... von Abdelmotilib, Hisham, Maltbie, Tyler, Delic, Vedad, Liu, Zhiyong, Hu, Xianzhen, Fraser, Kyle B., Moehle, Mark S., Stoyka, Lindsay, Anabtawi, Nadia, Krendelchtchikova, Valentina, Volpicelli-Daley, Laura A., West, Andrew

Volltext

The G2019S LRRK2 mutation increases myeloid cell chemotactic responses and enhances LRRK2 binding to actin-regulatory proteins von Moehle, Mark S, Daher, João Paulo Lima, Hull, Travis D, Boddu, Ravindra, Abdelmotilib, Hisham A, Mobley, James, Kannarkat, George T, Tansey, Malú G, West, Andrew B

Volltext

Allosteric activation of M₄ muscarinic receptors improve behavioral and physiological alterations in early symptomatic YAC128 mice von Pancani, Tristano, Foster, Daniel J., Moehle, Mark S., Bichell, Terry Jo, Bradley, Emma, Bridges, Thomas M., Klar, Rebecca, Poslusney, Mike, Rook, Jerri M., Daniels, J. Scott, Niswender, Colleen M., Jones, Carrie K., Wood, Michael R., Bowman, Aaron B., Lindsley, Craig W., Xiang, Zixiu, Conn, P. Jeffrey

Volltext

Inhibition of LRRK2 kinase activity rescues deficits in striatal dopamine physiology in VPS35 p.D620N knock-in mice von Bu, Mengfei, Follett, Jordan, Deng, Isaac, Tatarnikov, Igor, Wall, Shannon, Guenther, Dylan, Maczis, Melissa, Wimsatt, Genevieve, Milnerwood, Austen, Moehle, Mark S., Khoshbouei, Habibeh, Farrer, Matthew J.

Volltext

Roles of the M4 acetylcholine receptor in the basal ganglia and the treatment of movement disorders von Moehle, Mark S., Conn, P. Jeffrey

Volltext

Roles of the M 4 acetylcholine receptor in the basal ganglia and the treatment of movement disorders von Moehle, Mark S, Conn, P Jeffrey

Volltext

Mechanisms of GNAL linked dystonia von Moehle, Mark S.

Volltext

Cholinergic system changes in Parkinson's disease: emerging therapeutic approaches von Bohnen, Nicolaas I, Yarnall, Alison J, Weil, Rimona S, Moro, Elena, Moehle, Mark S, Borghammer, Per, Bedard, Marc-André, Albin, Roger L

Volltext

Anticholinergic drugs for parkinsonism and other movement disorders von LeWitt, Peter A., Hong, Luke, Moehle, Mark S.

Volltext

Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration von Daher, João P.L., Abdelmotilib, Hisham A., Hu, Xianzhen, Volpicelli-Daley, Laura A., Moehle, Mark S., Fraser, Kyle B., Needle, Elie, Chen, Yi, Steyn, Stefanus J., Galatsis, Paul, Hirst, Warren D., West, Andrew B.

Volltext

Urinary LRRK2 phosphorylation predicts parkinsonian phenotypes in G2019S LRRK2 carriers von Fraser, Kyle B, Moehle, Mark S, Alcalay, Roy N, West, Andrew B

Volltext

Neuron specific quantitation of Gαolf expression and signaling in murine brain tissue von Millett, Michael, Heuberger, Anika, Martin Castosa, Elisabeth, Comite, Allison, Wagner, Preston, Hall, Dominic, Gallardo, Ignacio, Chambers, Nicole E., Wagner, Lloyd, Reinhardt, Jessica, Moehle, Mark S.

Volltext

Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulators von Yohn, Samantha E., Foster, Daniel J., Covey, Dan P., Moehle, Mark S., Galbraith, Jordan, Garcia-Barrantes, Pedro M., Cho, Hyekyung P., Bubser, Michael, Blobaum, Anna L., Joffe, Max E., Cheer, Joseph F., Jones, Carrie K., Lindsley, Craig W., Conn, P. Jeffrey

Volltext

LRRK2 secretion in exosomes is regulated by 14-3-3 von Fraser, Kyle B, Moehle, Mark S, Daher, João P L, Webber, Philip J, Williams, Jeri Y, Stewart, Carrie A, Yacoubian, Talene A, Cowell, Rita M, Dokland, Terje, Ye, Tong, Chen, Dongquan, Siegal, Gene P, Galemmo, Robert A, Tsika, Elpida, Moore, Darren J, Standaert, David G, Kojima, Kyoko, Mobley, James A, West, Andrew B

Volltext

Development of a Selective and High Affinity Radioligand, [ 3 H]VU6013720, for the M 4 Muscarinic Receptor von Qi, Aidong, Kling, Haley E, Billard, Natasha, Rodriguez, Alice L, Peng, Li, Dickerson, Jonathan W, Engers, Julie L, Bender, Aaron M, Moehle, Mark S, Lindsley, Craig W, Rook, Jerri M, Niswender, Colleen M

Volltext

Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M 4 Muscarinic Receptor von Moehle, Mark S, Pancani, Tristano, Byun, Nellie, Yohn, Samantha E, Wilson, 3rd, George H, Dickerson, Johnathan W, Remke, Daniel H, Xiang, Zixiu, Niswender, Colleen M, Wess, Jürgen, Jones, Carrie K, Lindsley, Craig W, Rook, Jerri M, Conn, P Jeffrey

Volltext